ArticlePharmacoEconomics2017

Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin Lymphoma.

Kelly Fust et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.